153 related articles for article (PubMed ID: 28302652)
21. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation.
Sévigny J; Sundberg C; Braun N; Guckelberger O; Csizmadia E; Qawi I; Imai M; Zimmermann H; Robson SC
Blood; 2002 Apr; 99(8):2801-9. PubMed ID: 11929769
[TBL] [Abstract][Full Text] [Related]
22. A fusion protein of the human P2Y(1) receptor and NTPDase1 exhibits functional activities of the native receptor and ectoenzyme and reduced signaling responses to endogenously released nucleotides.
Alvarado-Castillo C; Lozano-Zarain P; Mateo J; Harden TK; Boyer JL
Mol Pharmacol; 2002 Sep; 62(3):521-8. PubMed ID: 12181428
[TBL] [Abstract][Full Text] [Related]
23. CD39 improves survival in microbial sepsis by attenuating systemic inflammation.
Csóka B; Németh ZH; Törő G; Koscsó B; Kókai E; Robson SC; Enjyoji K; Rolandelli RH; Erdélyi K; Pacher P; Haskó G
FASEB J; 2015 Jan; 29(1):25-36. PubMed ID: 25318479
[TBL] [Abstract][Full Text] [Related]
24. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
25. CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation.
Banz Y; Beldi G; Wu Y; Atkinson B; Usheva A; Robson SC
Br J Haematol; 2008 Aug; 142(4):627-37. PubMed ID: 18537971
[TBL] [Abstract][Full Text] [Related]
26. E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.
Aldi S; Marino A; Tomita K; Corti F; Anand R; Olson KE; Marcus AJ; Levi R
FASEB J; 2015 Jan; 29(1):61-9. PubMed ID: 25318477
[TBL] [Abstract][Full Text] [Related]
27. Constraints imposed by transmembrane domains affect enzymatic activity of membrane-associated human CD39/NTPDase1 mutants.
Musi E; Islam N; Drosopoulos JH
Arch Biochem Biophys; 2007 May; 461(1):30-9. PubMed ID: 17374358
[TBL] [Abstract][Full Text] [Related]
28. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.
Alvarado-Castillo C; Harden TK; Boyer JL
Mol Pharmacol; 2005 Jan; 67(1):114-22. PubMed ID: 15496502
[TBL] [Abstract][Full Text] [Related]
29. The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.
Barat C; Martin G; Beaudoin AR; Sévigny J; Tremblay MJ
J Mol Biol; 2007 Aug; 371(1):269-82. PubMed ID: 17560607
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of the P2Y1 receptor up-regulates nucleoside-triphosphate diphosphohydrolase-1 in human retinal pigment epithelial cells.
Lu W; Reigada D; Sévigny J; Mitchell CH
J Pharmacol Exp Ther; 2007 Oct; 323(1):157-64. PubMed ID: 17626796
[TBL] [Abstract][Full Text] [Related]
31. NTPDase1/CD39 Ectonucleotidase Is Necessary for Normal Arterial Diameter Adaptation to Flow.
Favre J; Roy C; Guihot AL; Drouin A; Laprise M; Gillis MA; Robson SC; Thorin E; Sévigny J; Henrion D; Kauffenstein G
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894719
[TBL] [Abstract][Full Text] [Related]
32. The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy.
Friedman DJ; Rennke HG; Csizmadia E; Enjyoji K; Robson SC
Diabetes; 2007 Sep; 56(9):2371-9. PubMed ID: 17473221
[TBL] [Abstract][Full Text] [Related]
33. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.
Leal DB; Streher CA; Neu TN; Bittencourt FP; Leal CA; da Silva JE; Morsch VM; Schetinger MR
Biochim Biophys Acta; 2005 Jan; 1721(1-3):9-15. PubMed ID: 15652174
[TBL] [Abstract][Full Text] [Related]
34. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection.
Eltzschig HK; Köhler D; Eckle T; Kong T; Robson SC; Colgan SP
Blood; 2009 Jan; 113(1):224-32. PubMed ID: 18812468
[TBL] [Abstract][Full Text] [Related]
35. NTPDase1 Modulates Smooth Muscle Contraction in Mice Bladder by Regulating Nucleotide Receptor Activation Distinctly in Male and Female.
Babou Kammoe RB; Kauffenstein G; Pelletier J; Robaye B; Sévigny J
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33498759
[TBL] [Abstract][Full Text] [Related]
36. E-NTPDase and E-ADA activities are altered in lymphocytes of patients with indeterminate form of Chagas' disease.
Souza Vdo C; Schlemmer KB; Noal CB; Jaques JA; Zimmermann CE; Leal CA; Fleck J; Casali EA; Morsch VM; Schetinger MR; Leal DB
Parasitol Int; 2012 Dec; 61(4):690-6. PubMed ID: 22846899
[TBL] [Abstract][Full Text] [Related]
37. N-linked oligosaccharides affect the enzymatic activity of CD39: diverse interactions between seven N-linked glycosylation sites.
Wu JJ; Choi LE; Guidotti G
Mol Biol Cell; 2005 Apr; 16(4):1661-72. PubMed ID: 15673609
[TBL] [Abstract][Full Text] [Related]
38. Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3).
Baek AE; Kanthi Y; Sutton NR; Liao H; Pinsky DJ
FASEB J; 2013 Nov; 27(11):4419-28. PubMed ID: 23901069
[TBL] [Abstract][Full Text] [Related]
39. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
40. Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3.
Fausther M; Pelletier J; Ribeiro CM; Sévigny J; Picher M
Am J Physiol Lung Cell Mol Physiol; 2010 Jun; 298(6):L804-18. PubMed ID: 20190036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
